BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26687261)

  • 21. Health Economic Evaluation of a Strict Glucose Control Guideline Implemented Using Point-of-Care Testing in Three Intensive Care Units in The Netherlands.
    van Hooijdonk RT; Steuten LM; Kip MM; Monteban H; Mulder MR; van Braam Houckgeest F; van der Sluijs JP; Abu-Hanna A; Spronk PE; Schultz MJ
    Appl Health Econ Health Policy; 2015 Aug; 13(4):399-407. PubMed ID: 25958191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating glycemic control algorithms by computer simulations.
    Wilinska ME; Blaha J; Chassin LJ; Cordingley JJ; Dormand NC; Ellmerer M; Haluzik M; Plank J; Vlasselaers D; Wouters PJ; Hovorka R
    Diabetes Technol Ther; 2011 Jul; 13(7):713-22. PubMed ID: 21488803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the glucometrics website to benchmark ICU glucose control before and after the NICE-SUGAR study.
    Lleva RR; Thomas P; Bozzo JE; Hendrickson KC; Inzucchi SE
    J Diabetes Sci Technol; 2014 Sep; 8(5):918-22. PubMed ID: 25013157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive insulin therapy for critically ill patients.
    Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
    Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive insulin therapy in practice: can we do it?
    Dossett LA; Collier B; Donahue R; Mowery NT; Dortch MJ; Guillamondegui O; Diaz JJ; May AK
    JPEN J Parenter Enteral Nutr; 2009; 33(1):14-20. PubMed ID: 18832598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit.
    Clayton SB; Mazur JE; Condren S; Hermayer KL; Strange C
    Crit Care Med; 2006 Dec; 34(12):2974-8. PubMed ID: 17075371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal target range for blood glucose in hyperglycaemic patients in a neurocritical care unit.
    Guo YJ; Zhou Y; Zhang SY; Wei Q; Huang Y; Xia WQ; Wang SH
    Diab Vasc Dis Res; 2014 Sep; 11(5):352-8. PubMed ID: 24925103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
    Chant C; Wilson G; Friedrich JO
    Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to treatment 1: How is type 2 diabetes actually treated?
    Bloomgarden ZT
    J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycemic targets and approaches to management of the patient with critical illness.
    Mesotten D; Van den Berghe G
    Curr Diab Rep; 2012 Feb; 12(1):101-7. PubMed ID: 22090208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safe and effective use of a glycemic control protocol for neonates in a cardiac ICU.
    Hebson CL; Chanani NK; Rigby MR; Wolf MJ; Deshpande SR; Montegna LM; Maher KO
    Pediatr Crit Care Med; 2013 Mar; 14(3):284-9. PubMed ID: 23392366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.
    Krinsley JS
    Mayo Clin Proc; 2004 Aug; 79(8):992-1000. PubMed ID: 15301325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose control in critically ill patients.
    Braithwaite SS
    N Engl J Med; 2009 Jul; 361(1):89-90; author reply 91-2. PubMed ID: 19579271
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of a clinical decision support system for glucose control: impact of protocol modifications on compliance and achievement of glycemic targets.
    Lipton JA; Barendse RJ; Akkerhuis KM; Schinkel AF; Simoons ML
    Crit Pathw Cardiol; 2010 Sep; 9(3):140-7. PubMed ID: 20802267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding glycemic control in the critically ill: 2011 update.
    Krinsley JS
    Hosp Pract (1995); 2011 Apr; 39(2):47-55. PubMed ID: 21576897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials.
    Ling Y; Li X; Gao X
    Eur J Intern Med; 2012 Sep; 23(6):564-74. PubMed ID: 22863436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study.
    Bland DK; Fankhanel Y; Langford E; Lee M; Lee SW; Maloney C; Rogers M; Zimmerman G
    Am J Crit Care; 2005 Sep; 14(5):370-6. PubMed ID: 16120888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo changes in blood glucose levels seldom change blood glucose control algorithm recommendations.
    De Groene L; Harmsen RE; Binnekade JM; Spronk PE; Schultz MJ
    Minerva Anestesiol; 2010 Dec; 76(12):1018-23. PubMed ID: 20585307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
    Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
    Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.